The appeal of the approach lies in its chemistry of substitution. Standard routes to nickel oxide nanoparticles, including sol-gel processing, chemical precipitation, hydrothermal synthesis, combustion methods, and thermal decomposition, typically demand high temperatures, expensive instrumentation, and reagents that generate environmentally harmful by-products. Plant-mediated synthesis replaces all of that with phytochemicals. Leaves of Zanthoxylum rhetsa, a Rutaceae family tree distributed across South and Southeast Asia and long used in Ayurvedic medicine, are rich in flavonoids, phenolics, alkaloids, and essential oils. In the synthesis, these biomolecules perform double duty: they chemically reduce nickel ions from a nickel chloride precursor into nanoscale nickel oxide, and they cap the growing particles, preventing them from clumping and controlling their size and shape.

The practical procedure was strikingly simple. Fresh leaves collected from Satarda village in the Sawantwadi region of Sindhudurg were shade-dried, ground, and boiled in distilled water for an hour to extract the phytochemicals. The filtered extract was then mixed one-to-one with a 0.1 molar nickel chloride solution and stirred magnetically for eight hours, during which a deep brown precipitate appeared, signaling nanoparticle formation. After centrifugation, repeated washing, drying at 110 degrees Celsius, and calcination at 550 degrees Celsius, the team obtained phase-pure brown ZR-NiONPs ready for characterization and biological testing.

X-ray diffraction confirmed that the material was genuine face-centered cubic nickel oxide, with diffraction peaks matching the standard reference pattern and indexing to the (111), (200), (220), (311), and (222) crystal planes. Applying the Scherrer equation to the peak widths gave an average crystallite size of just 12.88 nanometers, and the sharpness of the peaks indicated high crystallinity with minimal lattice strain. Ultraviolet-visible spectroscopy added a second confirmation: while the raw leaf extract absorbed at 289 nanometers, a signature of the aromatic polyphenols and flavonoids within it, the finished nanoparticles showed a distinct new absorption band at 476 nanometers, reflecting defect-induced electronic transitions characteristic of nickel oxide nanoscale particles.

Infrared spectroscopy told the mechanistic story in detail. The extract spectrum displayed a rich catalog of functional groups, including broad hydroxyl stretching from phenols, aliphatic carbon-hydrogen stretches from terpenoids, carbonyl and amide bands from proteins and phenolic compounds, and aromatic ring vibrations typical of flavonoids. After synthesis, several of these bands shifted or weakened, evidence that those biomolecules had been consumed in reducing and capping the particles, and a set of entirely new peaks between roughly 550 and 430 inverse centimeters appeared, corresponding to nickel-oxygen stretching vibrations. Electron microscopy completed the physical portrait: field emission scanning electron microscopy revealed spherical to irregular, agglomerated, rough-surfaced particles, while transmission electron microscopy resolved individual particles ranging from 10 to 42 nanometers, with a selected area electron diffraction pattern of bright concentric rings confirming their polycrystalline nature.

Two further measurements rounded out the physicochemical profile. Zeta potential analysis gave a value of minus 10.2 millivolts, indicating a moderately negative surface charge and only moderate colloidal stability, a common feature of plant-capped metal oxide nanoparticles whose stability derives from both electrostatic repulsion and steric shielding by adsorbed biomolecules. More dramatically, vibrating sample magnetometry revealed a saturation magnetization of approximately plus or minus 55 emu per gram with near-zero coercivity and remanence, a soft ferromagnetic signature. That magnetic character matters beyond the laboratory bench: soft ferromagnetic nanoparticles are candidates for spintronic devices, magnetic data storage, heterogeneous catalysis, and, in a biomedical context, magnetically guided delivery.

The biological results were the study’s most eye-catching element. In agar well diffusion tests, the nanoparticles produced inhibition zones of 18 to 23 millimeters against four clinically relevant bacterial strains, with the strongest effect against Staphylococcus aureus, followed by Bacillus cereus, Escherichia coli, and Proteus vulgaris. The authors attribute this activity primarily to reactive oxygen species. Nickel oxide nanoparticles generate superoxide radicals, hydroxyl radicals, and hydrogen peroxide at the cell surface, and these species attack membrane lipids, proteins, and DNA, ultimately rupturing the bacterial cell. Released nickel ions may add a second mechanism by binding thiol groups in cellular enzymes. Notably, the particles performed better against Gram-positive bacteria, whose thick peptidoglycan wall lacks the outer lipopolysaccharide membrane that shields Gram-negative species from nanoparticle penetration.

The antifungal and metabolic assays painted a picture of moderate but genuine multifunctionality. The nanoparticles inhibited Candida albicans with an 11 millimeter zone and Aspergillus niger with 9 millimeters, below the performance of standard drugs but consistent with other plant-derived nickel oxide systems. In a DPPH free radical scavenging assay they achieved an IC50 of 92.56 micrograms per milliliter, roughly double the potency of ascorbic acid in the same test, and in a heat-induced protein denaturation model of inflammation they reached 48.83 percent inhibition at 100 micrograms per milliliter. They also inhibited the alpha-amylase enzyme central to starch digestion with an IC50 of 97.71 micrograms per milliliter, suggesting potential as a complementary agent in managing postprandial blood glucose, and they suppressed Mycobacterium tuberculosis growth by 46.24 percent at the highest tested concentration of 1000 micrograms per milliliter in an Alamar Blue viability assay.

Perhaps the most clinically significant finding came from the cell culture work. Against MCF-7 human breast cancer cells, the nanoparticles showed dose-dependent cytotoxicity with an IC50 of 88.52 micrograms per milliliter, an effect the authors link to the same reactive oxygen species machinery that kills bacteria: excessive oxidative stress in cancer cells damages mitochondria, fragments DNA, and triggers apoptosis, with surface-bound Zanthoxylum phytochemicals potentially enhancing uptake across cancer cell membranes. Crucially, when the same particles were tested against L929 mouse fibroblast cells, a standard model for normal tissue biocompatibility, inhibition never exceeded 29.40 percent even at 1000 micrograms per milliliter, and no IC50 could be determined. The phytochemical capping layer, the researchers suggest, moderates surface reactivity and limits oxidative damage in healthy cells, which possess their own antioxidant defenses, while cancer cells, already living near their redox limits, succumb.

The authors are candid about the caveats. Plant-mediated synthesis remains difficult to standardize, since phytochemical composition varies with plant origin, season, and extraction method, and scaling the process to industrial levels is unproven. No in vivo toxicology or long-term environmental assessment has yet been performed, and the anticancer and anti-tubercular effects, while real, trail standard drugs by a considerable margin. Even so, the study stands out for integrating a full physicochemical characterization with a systematic panel of biomedical assays in a single investigation, something the authors note is rare in the field. If subsequent animal studies confirm the safety margin seen in fibroblasts, these leaf-forged ferromagnetic particles could find roles in antimicrobial coatings, drug delivery platforms, biosensors, and wound healing formulations, all built from a tree that traditional medicine has valued for centuries.

Subject of Research: Green synthesis of nickel oxide nanoparticles using Zanthoxylum rhetsa leaf extract and their multifunctional biomedical activities

Article Title: Green synthesis of nickel oxide nanoparticles using Zanthoxylum rhetsa (Roxb.) DC. leaf extract, comprehensive physicochemical characterisation and multifunctional biomedical applications

Article References: Kale, S. S., Nikum, A. P., Pawar, Y. A., Gurav, V. L., & Sathe, G. B. (2026). Green synthesis of nickel oxide nanoparticles using Zanthoxylum rhetsa (Roxb.) DC. leaf extract, comprehensive physicochemical characterisation and multifunctional biomedical applications. Discover Green Chemistry, 1(1), Article 15. https://doi.org/10.1007/s44509-026-00018-y

Image Credits: AI Generated

DOI: 10.1007/s44509-026-00018-y

Keywords: green synthesis, nickel oxide nanoparticles, Zanthoxylum rhetsa, phytochemicals, antibacterial activity, anticancer activity, ferromagnetism, nanomedicine, reactive oxygen species, MCF-7 breast cancer cells, biocompatibility, Ayurvedic medicinal plants

Salvia is one of the largest genera in the mint family, encompassing more than a thousand species ranging from culinary sage to ornamental salvias cultivated in gardens worldwide. Many members of the genus produce an abundant secondary metabolome: essential oils, phenolic acids, flavonoids, and, critically for this study, diterpenoids. Abietane diterpenoids, named for their structural resemblance to abietic acid from pine resin, have long attracted attention from natural products chemists because several representatives of the class display antimicrobial, anti-inflammatory, and cytotoxic activities in laboratory assays. Salvia oligophylla, native to Turkey and neighboring regions, has received comparatively little research attention, making it an underexplored reservoir of potentially bioactive chemistry.

The research team focused their investigation on the roots of the plant, an organ in which salvia species tend to concentrate their diterpenoid production. Rather than attempting to isolate a single pure compound from the outset, the researchers prepared a fraction of the root extract deliberately enriched in abietane diterpenoids. This fraction-based approach reflects a common strategy in pharmacognosy, the study of medicines derived from natural sources. Complex plant extracts contain hundreds of constituents, and chemical complexity can obscure which molecules are responsible for a biological effect. By concentrating one chemical class and testing the resulting fraction, scientists can gather stronger evidence about which family of compounds drives the observed activity while preserving the possibility of synergistic interactions between related molecules.

With the diterpenoid-rich fraction in hand, the investigators turned to MCF-7 cells, a breast cancer cell line first isolated in 1973 from a patient with metastatic mammary carcinoma and since become one of the most widely used models in breast cancer research. MCF-7 cells are particularly informative in apoptosis studies because they express estrogen receptors and retain key elements of the cellular machinery that governs programmed cell death, including p53, a tumor suppressor protein often described as the guardian of the genome. Testing candidates against MCF-7 cells provides a standardized, reproducible benchmark for comparing the cytotoxic potential of new compounds against decades of published results.

Apoptosis is an attractive mechanism to look for in candidate anti-cancer agents. Unlike necrosis, the messy form of cell death that ruptures cells and triggers inflammation, apoptosis proceeds through an orderly sequence of biochemical events. Cells shrink, their membranes bleb, their DNA is chopped into characteristic fragments by dedicated enzymes, and the cellular debris is quietly dismantled and recycled. In a healthy body, apoptosis eliminates damaged or surplus cells. Cancer cells, however, frequently rewire the pathways that control this process, rendering them resistant to the self-destruct signals that would otherwise remove them. A compound that can re-engage the apoptotic program in tumor cells therefore addresses one of the central hallmarks of cancer biology.

The study’s results indicate that the abietane diterpenoid-rich fraction from Salvia oligophylla roots suppressed the viability of MCF-7 cells in a manner consistent with apoptosis induction. Assessments of cell survival following treatment demonstrated a dose-dependent reduction in the number of living cancer cells, suggesting that the bioactive constituents become more potent as their concentration increases—a pattern expected of a genuine pharmacological effect rather than random experimental noise. The researchers further examined markers associated with programmed cell death to characterize how the treated cells were dying, distinguishing apoptosis from other forms of growth inhibition such as simple cytostasis, in which cells stop dividing but do not die.

Understanding exactly how abietane diterpenoids push cancer cells toward apoptosis remains an active area of investigation. Work on structurally related compounds from other plant species has suggested several plausible mechanisms. Some diterpenoids appear to generate oxidative stress within tumor cells, overwhelming the antioxidant defenses that many cancers rely upon and tipping the cell into self-destruction. Others influence the balance of pro- and anti-apoptotic proteins of the Bcl-2 family, the molecular gatekeepers that determine whether the mitochondrial pathway of apoptosis is activated. Still others interfere with the cell cycle, preventing cancer cells from progressing through DNA replication and division, which can in turn trigger apoptotic checkpoints. The present study’s characterization of the Salvia oligophylla fraction contributes to this broader mechanistic picture while leaving room for further dissection of the precise molecular targets involved.

The significance of the work extends beyond the specific plant involved. Natural products have historically furnished a striking proportion of the drugs in clinical use, particularly in oncology. Paclitaxel, one of the most famous chemotherapy agents, was originally isolated from the bark of the Pacific yew; vincristine came from the Madagascar periwinkle; and etoposide derives from a compound found in the roots of the mayapple. Estimates from cancer pharmacology suggest that a majority of anticancer drugs approved in recent decades are either natural products, derivatives of natural products, or synthetic molecules whose design was inspired by natural product structures. Sage plants, with their rich diterpenoid chemistry, have been on the radar of natural product drug hunters for years, and investigations of lesser-known species such as Salvia oligophylla broaden the search space from which future leads might emerge.

At the same time, the researchers and the wider field are careful to contextualize results obtained in cell culture. A cytotoxic effect observed against MCF-7 cells in a laboratory dish is a promising early signal, not a therapy. Countless compounds that kill cancer cells in vitro fail at later stages of development because they lack selectivity, are too toxic to healthy tissue, are poorly absorbed, or are rapidly metabolized in the body. The essential next steps for this line of research would include identifying and isolating the individual abietane diterpenoids responsible for the activity, testing them against non-cancerous cell lines to gauge their therapeutic window, exploring activity across a panel of breast cancer subtypes, and eventually evaluating pharmacokinetic behavior in more sophisticated preclinical models. Fraction-based studies like this one are best understood as cartography: they chart promising regions of chemical space that merit closer exploration.

Nevertheless, the report offers a concrete example of how biodiversity and cancer research intersect. Salvia oligophylla is not a commercially prominent medicinal plant, and studies of its chemistry contribute to documenting the pharmacological potential of species that may face habitat pressures even as their biochemical treasures remain largely unmapped. Each new demonstration that an underexplored plant yields fractions with well-defined activity against established cancer models reinforces the case for sustained investment in natural product research, bioprospecting with appropriate ethical frameworks, and conservation of the ecosystems where these chemical innovations evolved. Whether the abietane diterpenoids of this Turkish sage will ultimately inspire a drug candidate remains an open question, but the pathway from root extract to apoptotic trigger traced in this study illustrates the incremental, exacting process by which nature’s chemistry is translated into the vocabulary of modern cancer pharmacology.

Subject of Research: Apoptosis-inducing activity of abietane diterpenoid-rich fractions from Salvia oligophylla roots against breast cancer cells.

Article Title: Apoptosis-inducing activity of an abietane diterpenoid-rich fraction from Salvia oligophylla roots against MCF-7 cancer cells

Article References: Jalilvand, R., Hassani, N., Bagheri, M., Kamkar, N., Ayatollahi, S. A., Farhadpour, M., Nemati, F., Esmaeili, H., Samani, F. S., Ajani, Y., Ghanbari, H., & Zadali, R. (2026). Apoptosis-inducing activity of an abietane diterpenoid-rich fraction from Salvia oligophylla roots against MCF-7 cancer cells. Scientific Reports. https://doi.org/10.1038/s41598-026-71150-9

Image Credits: AI Generated

DOI: 10.1038/s41598-026-71150-9

Keywords: Salvia oligophylla, abietane diterpenoids, apoptosis, MCF-7 breast cancer cells, natural products, cytotoxicity, plant secondary metabolites, cancer drug discovery, pharmacognosy, Scientific Reports, programmed cell death, medicinal plants